Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use
NCT ID: NCT06171412
Last Updated: 2025-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
38 participants
INTERVENTIONAL
2024-05-21
2027-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Reinforcement Approach to Increase Use of CGM
NCT02907346
Can Glucose Monitoring Improve (CGMi Study)
NCT01472159
Web-Based Intervention Designed to Educate and Improve Adherence Through Learning to Use Continuous Glucose Monitoring
NCT03367351
GO TEAM: Glucose Optimization Through Technology Assisted Management
NCT06074458
Research on Optimizing the Use of Technology With Education
NCT05564481
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All study procedures will be conducted remotely by ZOOM, including consent/assent, device and training, and peer mentor sessions.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Glu-COACH
The experimental group will receive ESOC plus peer-mentoring support from a peer of the same cultural identity (Glu-COACH) and access to a private social media group for all Black and Latinx teens to improve the initiation and maintenance of CGM (Dexcom)
Glu-COACH
peer-mentoring support from a peer of the same cultural identity and access to a private social media group for all Black and Latinx teens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glu-COACH
peer-mentoring support from a peer of the same cultural identity and access to a private social media group for all Black and Latinx teens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Self-identification as Black and/or Latinx.
* Ability of participant to comprehend and communicate in written and spoken English, in order to complete surveys and participate in mentioning sessions and other interview (parents/caregivers do not need to have English fluency)
* Access to personal cellphone or tablet to participate in remote video sessions with the peer mentor
* using CGM \<50% of the time over the last 3 months
Exclusion Criteria
* Current use of CGM
* Current or planned pregnancy
* Inability to comprehend or communicate in spoken/written English
* Subjects with other medical or mental health conditions that would, in the opinion of the investigators, interfere with the conduct of the study or present additional risk to the individual.
13 Years
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robin Whittemore, PhD, APRN, FAAN
Role: PRINCIPAL_INVESTIGATOR
Yale School of Nursing
Stuart A Weinzimer, MD
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale Children's Diabetes Clinic
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000033606
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.